Stephen W. Webster, Director at Nabriva Therapeutics plc (NBRV), bought 8,000 shares at $4.59 ($37K) on 2018-05-23, disclosed to the SEC on 2018-05-23.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| Filing → |
| VKTX | BUY | 2018-05-31 | $42K | — | Filing → |
| ONCE | SELL | 2017-11-20 | $701K | — | Filing → |
| ONCE | SELL | 2017-08-15 | $794K | — | Filing → |